Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_assertion description "[Preclinical studies have demonstrated single-agent antitumor activity of GEM 231 in a variety of human cancer xenograft models, and additive or synergistic antitumor activity has been observed with taxane and/or camptothecin-based combinations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_assertion evidence source_evidence_literature NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_assertion SIO_000772 14751840 NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_assertion wasDerivedFrom befree-20150227 NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_assertion wasGeneratedBy ECO_0000203 NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP422905.RApZ2LEeg1PTgDQLiukx8m82ZqwaHNe5R1OxbROT1DsNY130_provenance.